The proposed DNet framework provides a robust and efficient framework for medical image segmentation and achieves higher accuracy in small tumor regions by combining Dice loss and weighted cross-entropy (WCE) loss.
Abstract
Localization of brain tumors via magnetic resonance imaging (MRI) is critically important for diagnosis, treatment, and surgical operations. This study proposes DNet, an optimized and highly efficient deep learning framework for the automatic detection and segmentation of brain tumors from MR images. On the basis of the classical UNet structure, DNet reduces the risk of overfitting by balancing the integration of batch normalization and dropout layers; it also achieves higher accuracy in small tumor regions by combining Dice loss and weighted cross-entropy (WCE) loss. To improve the model's robustness and predictive stability, an ensemble and test-time augmentation (TTA) were applied during testing. The dataset used in the study consisted of 1664 MR images containing three tumor classes: glioma, meningioma, and pituitary. Data preprocessing and augmentation steps, including contrast correction, reflection, and cropping, were applied to the images. The model was trained via the five-fold cross-validation method; the mean intersection-over-union (mIoU) and accuracy were used for evaluation. The experimental results demonstrate improved performance over the classical UNet. The DNet model achieved competitive performance compared with existing approaches in the literature, reaching 99.6% accuracy and a test mIoU value of 0.8617 on a three-class dataset. Furthermore, ablation studies revealed that reducing the number of classes increased the model's mIoU by approximately 3%. In conclusion, the proposed DNet framework provides a robust and efficient framework for medical image segmentation. In addition to the primary dataset, consistent performance was also observed on an independent dataset, supporting the robustness of the proposed approach. Nevertheless, further validation on diverse and multi-center datasets is required for real-world clinical deployment.
Brain tumor segmentation from Magnetic Resonance Imaging (MRI) is an important task in computer-aided diagnosis because accurate identification of tumor regions supports clinical assessment and treatment planning. However, the complex structure, irregular shape, intensity variation, and heterogeneous appearance of brai...
Lovedeep Kaur, Parminder Singh, Naveen Dhillon· International Journal of Com...· 0 citations
The segmentation of brain tumors in multimodal magnetic resonance imaging (MRI) is an important task in the clinical diagnosis, treatment planning and disease monitoring processes. The accurate delineation is however difficult because of the heterogeneity of tumors, irregularity of their borders and the different inten...
Rashmi Ashtagi· Natural Resources for Human...· 0 citations
The segmentation of brain tumors from magnetic resonance imaging (MRI) is an essential step for computeraided neuro-oncology, treatment planning and follow-up. While U-Net and Attention U-Net achieve effective encoder-decoder representations, the skip connections in these networks can produce low-contrast or noisy resp...
A. Saiyed, Nitesh Chilakala, Jimmy Joseph et al.· International Conference Com...· 0 citations
This research systematically benchmarks five CNN architectures (VGG19, DenseNet201, ResNet50, Inception-v3, and MobileNet) on balanced and naturally imbalanced MRI datasets, suggesting that VGG19 is particularly good at discriminative performance.
Tegar Anugrah Firdaus, B. Rais, Marcelinus Jonathan Salim et al.· 0 citations
Brain tumor classification from magnetic resonance imaging (MRI) plays an important role in computer-aided diagnosis, as accurate identification of tumor categories can support clinical decision-making and reduce the burden associated with manual image interpretation. This study proposes a hybrid deep learning framewor...
Ahmed Thijeel· Alkadhim Journal for Compute...· 0 citations
The early and accurate diagnosis of brain tumors is critically important, as timely intervention significantly reduces mortality and improves patient outcomes. While magnetic resonance imaging (MRI) is the preferred diagnostic tool, differentiating malignant brain tumors from benign cysts remains a clinical challenge d...
Mete Yağanoğlu, Oznur Ozaltin, Orhan Coşkun· Big Data· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.